1,248
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, antifungal and antioxidant screening of some novel benzimidazole derivatives

, , , &
Pages 696-701 | Received 18 Jul 2006, Accepted 29 Sep 2006, Published online: 04 Oct 2008

Abstract

Some novel benzimidazole derivatives were synthesized and their in vitro effects on rat liver microsomal NADPH-dependent lipid peroxidation (LP) level, ethoxyresorufin O-deethylase (EROD) and antifungal activities were determined. A significant decrease in male rat liver microsomal LP level was noted by compounds 4c (52%), 4e (58%) and 4h (43%) at 10− 3 M concentration. Compounds 4c (100.0%), 4h (100.0%), 5c (98.0%) and 5h (100.0%) inhibited the microsomal ethoxyresorufin O-deethylase (EROD) enzyme activity better than that of the specific inhibitor caffeine (85%). Among these compounds, only compounds 4b and 4h exhibited moderate activity against C.albicans whereas the others had weak effects.

Introduction

In recent years, there has been an increasing interest in molecular oxygen derived free radicals such as superoxide (), hydroxyl (OH·), and peroxyl (ROO·) radicals, and hydrogen peroxide (H2O2) which are products of normal aerobic metabolic processes. Free radicals have been implicated in a variety of human diseases, ranging from atherosclerosis, to cancer, to neurodegenerative disorders [Citation1,Citation2]. These molecules are unstable and highly reactive and can damage cells by chemical chain reactions such as lipid peroxidation. On the other hand, all living organisms contain antioxidant enzymes systems and the major action of antioxidant enzymes systems/antioxidants in the cell is to prevent damage due to free radicals.

In addition, reactive oxygen species are produced by different mechanisms such as cytochrome P 450s (CYPs). CYPs are a superfamily of enzymes involved in the oxidation of numerous xenobiotics. For example, CYP1A1/2 activates polycylic aromatic hydrocarbons to their ultimate, mutagenic or carcinogenic metabolites. Moreover, CYP1A1/2, which catalyzes ethoxyresorufin O-deethylase (EROD) activity, is effective in producing reactive oxygen species [Citation3].

Ketoconazole, a well known azole antifungal drug, was found to inhibit lipid peroxidation in both microsomal and liposomal systems. In addition, it was observed that the fungistatic effect of ketoconazole on Candida species was associated with its membrane stabilizing effects as indicated by inhibition of lipid peroxidation [Citation4].

Previously, we reported the synthesis, antioxidant Citation5-7 and antimicrobial [Citation8,Citation9] activities of benzimidazole derivatives and some of them have proved promising antioxidants in vitro.

As part of our ongoing research program on benzimidazoles we prepared a new series of benzimidazoles and determined their in vitro antifungal activities and antioxidant effects by measuring NADPH-dependent lipid peroxidation (LP) level and 7-ethoxyresorufin O-deethylase (EROD) activity from rat liver were.

Materials and methods

Chemistry

Melting points were determined with an Electrothermal (Electrothermal Eng. Ltd., Essex, UK) and a Büchi SMP-20 (Büchi Laboratoriumstechnik, Flawil, Switzerland) melting point apparatus and are uncorrected. IR spectra were recorded on a Jasco FT/IR 420 spectrometer (Jasco Corp., Tokyo, Japan) as potassium bromide discs. 1H NMR spectra were measured with a Varian Mercury 400, 400 MHz instrument (California, USA) using TMS as internal standard and DMSO-d6. All chemical shifts were reported as δ (ppm) values. ESMS were obtained with a Waters ZQ Micromass LC-MS spectrometer (Milford, USA) with Positive Electrospray Ionization method. Elemental analyses (C, H, and N) were determined on a Leco CHNS 932 instrument (St.Joseph, USA), and were within 0.4% of the theoretical values. 1H NMR and Mass analyses were performed at Ankara University, Faculty of Pharmacy. Elemental analyses were performed at Scientific and Technical Research Council of Turkey. ATCC strains of the fungi were obtained from the culture collection of Refik Saydam Health Institution of Health Ministry, Ankara, Turkey. The chemical reagents used in synthesis were from E. Merck (Darmstadt, FRG) and Aldrich (Milwaukee, USA).

General procedure for the preparation of the thiosemicarbazides (1-(substituted thiocarbamoyl- hydrazinecarbonyl) methyl 2-(4-cyanophenyl)-1H-benzimidazoles) (4a-)

0.54 g Acid hydrazide (2.03 mmol) in absolute ethanol (20 mL) and appropriate isothiocyanate (3.05 mmol) were heated under reflux for 1 h. Precipitate formed was cooled, filtered and recrystallized from ethanol or isopropanol.

General procedure for the preparation of the [5-(2-(4-cyanophenyl) benzimidazol-1-yl methyl)-[1,3,4]-thiadiazole-2-yl-substituted phenyl amines (5a,5c,5e, 5f, 5h)

Appropriate thiosemicarbazide 4a, 4c, 4e, 4f, 4h (3.4 mmol) in 10 mL ice-cold concentrated sulfuric acid was stirred for 10 min, and then left for a further 10 min at room temperature. The resulting solution was poured slowly into ice-cold water, made alkaline to pH 8 with aqueous ammonia and the precipitated product was filtered, washed with water and crystallized from ethanol.

Biological evaluation

Antioxidant activity studies

Lipid peroxidation assay

Male albino Wistar rats (200–225 g) were used in the experiments. Animals were fed with standard laboratory rat chow and tap water ad libitum. The animals were starved for 24 h prior to sacrifice and then killed by decapitation under anaesthesia. The livers were removed immediately and washed in ice-cold water and the microsomes were prepared as described previously [Citation10].

NADPH-dependent LP was determined using the optimum conditions determined and described previously [Citation10]. NADPH-dependent LP was measured spectrophotometrically by estimation of thiobarbituric acid reactant substances (TBARS). Amounts of TBARS were expressed in terms of nmol malondialdehyde (MDA)/mg protein. The assay was essentially derived from the methods of Wills [Citation11,Citation12] as modified by Bishayee [Citation13]. A typical optimized assay mixture contained 0.2 nM Fe++, 90 mM KCl, 62.5 mM potassium-phosphate buffer, pH 7.4, NADPH generating system consisting of 0.25 mM NADP+, 2.5 mM MgCl2, 2.5 mM glucose-6-phosphate, 1.0 U glucose-6-phosphate dehydrogenase and 14.2 mM potassium phosphate buffer pH 7.8 and 0.2 mg microsomal protein in a final volume of 1.0 ml.

EROD assay

7-Ethoxyresorufin O-deethylase (EROD) activity was measured by the spectrofluorometric method of Burke et al. [Citation14]. A typical optimized assay mixture contained 1.0 mM ethoxyresorufin, 100 mM Tris-HCl buffer pH 7.8, NADPH generating system consisting of 0.25 mM NADP+, 2.5 mM MgCl2, 2.5 mM glucose-6-phosphate, 1.0 U glucose-6-phosphate dehydrogenase and 14.2 mM potassium phosphate buffer pH 7.8 and 0.2 mg liver microsomal protein in a final volume of 1.0 mL.

Antifungal activity assay

Some of the compounds were tested for their antifungal activities by the agar diffusion method [Citation15] using C. albicans ATCC 10231 and C. krusei ATCC 6258 as test organisms. A paper disc (8mm in diameter) was soaked in a 200 μg/ml solution of the test compounds in dimethylsulphoxide and placed on an agar plate containing fungi cells, which was incubated at 37°C for 24 h. The diameter of the growth inhibition zone around the paper disc was measured.

Results and discussion

For the synthesis of the target compounds the reaction sequences outlined in Scheme , were followed. 2-(4-Cyanophenyl)-1H-benzimidazole (M.P:265°C, Lit. M.P: 262.5°C [Citation16]) was prepared via oxidative condensation of o-phenylenediamine, 4-cyanobenzaldehyde and sodium metabisulfite [Citation17]. Treatment of 2-(4-cyanophenyl)-1H-benzimidazole with ethyl chloroacetate in KOH/DMSO gave the N-alkylated product, (2-(4-cyanophenyl)-benzimidazol-1-yl)-acetic acid ethyl ester (2) [M.P:152°C, IR cm− 1: 2229; 1H NMR 1.1 (t, 3H, CH3), 4.09 (q, 2H, CH2), 7.29-7.33 (m, 2H, H-5,6), 7.64 (d, 1H, H-7), 7.74 (d, 1H, H-4), 7.92 (d, 2H, H-3′,5′), 8.03 (d, 2H, H-2′,6′); Mass m/e 307 (M + H)]. Hydrazine hydrate and the ester (2) in ethanol were refluxed for 4 h to give the desired hydrazide compound, (2-(4-cyanophenyl)-benzimidazol-1-yl)-acetic acid hydrazide (3), in 86% yield [M.P:277°C, IR cm− 1:2226; 1H NMR 4.37 (br s, 1H, NH2), 4.87 (s, 1H, -CH2), 7.26-7.33 (m, 2H, H-5,6), 7.51 (d, 1H, H-7), 7.72 (d, 1H, H-4), 8.00-8.07 (m, 4H, H-2′,3′,5′,6′); Mass m/e 293 (M + H)]. The thiosemicarbazides (Scheme ) were obtained upon reaction of the acid hydrazide with aryl isothiocyanates in ethanol. Cyclization with sulfuric acid resulted in the formation of 1-(5-substituted amino-1,3,4-thiadiazole-2-yl)benzimidazoles. Some physico-chemical properties and spectral data of the compounds are given in .

Scheme 1 Synthetic route for the preparation of the compounds.

Scheme 1 Synthetic route for the preparation of the compounds.

Table I.  Physical and spectral data for the compounds.

In the IR spectra –C = N stretching bonds were observed at 2222–2239 cm− 1. The conversion of thiosemicarbazides to thiadiazoles was monitored by the disappearance of C = O strong stretching bands at 1674–1732 cm− 1 and the appearance of medium bands at 1592–1695 cm− 1 for C = N stretching.

All of the compounds showed lower antifungal activity potencies than the control fluconazole against C.albicans and C.krusei (). Among the investigated compounds 4b, 4h against C.albicans and 4b and 5h against C.krusei showed good activity. Compound 4h exhibited the best activity against C.albicans which was close to fluconazole.

Table II.  The in vitro antifungal activity of the compounds.

The NADPH-dependent lipid peroxidation inhibition produced by compounds in the rat liver microsomes was examined by measuring the formation of the 2-thiobarbituric acid reactive substances for their antioxidant capacity. A significant decrease in rat liver microsomal LP levels was determined for compounds 4c, 4e and 4h at 10− 3 M concentrations (). The most active compound was found to be 4e causing 58% inhibition of LP at a concentration of 10− 3M. The inhibition achieved by 4e was very close to that obtained for butylated hydroxytoluene (BHT) (65%). Compounds 4c and 4h exhibited moderately inhibition (52% and 43%) of LP at 10− 3M. Compound 4a (15%) showed rather limited inhibition of lipid peroxidation but compounds 4d and 4f enhanced LP by 16% and 86%, respectively.

Table III.  The in vitro effects of some compounds on liver LP levelsa.

The in vitro effect of compounds and caffeine on liver microsomal EROD activity are shown in . All the tested compounds except compound 4d (75%) showed significant inhibition (62%–100.0%) of EROD activity. Compounds 4c, 4h, 4ı, 5c and 5h decreased liver EROD activity by 100.0%, 100.0%, 90%, 98.0% and 100.0%, respectively, better than the specific inhibitor caffeine (85%). Compound 4g caused 81% inhibition which was close to caffeine. Significant inhibitory activities were also observed for compounds 4a (64%), 4e (67%), 4f (62%) and 5a (65%). In this series of compounds, those bearing a m-chloro/bromo substituent in the Ar ring in either the thiosemicarbazide or thiadiazole series were the most active compounds.

Table IV.  The in vitro effects of some compounds and caffeine on EROD enzyme activity in the livera.

References

  • Rice-Evans C, Diplock AT. Techniques in free radical research. Elsevier, Amsterdam 1991; 291
  • Richardson SJ. Free radicals in the genesis of Alzheimer's disease. Ann NY Acad Sci 1993; 695: 73–76
  • Parke DV, Ioannides C, Lewis DFV. The role of the cytochrome P450 in the detoxication and activation of drugs and other chemicals. Can J Physiol Pharmacol 1991; 69: 537–549
  • Wiseman H, Smith C, Arnstein HR, Halliwell B, Cannon M. The antioxidant action of ketoconazole and related azoles: Comparison with tamoxifen and cholesterol. Chem Biol Interact 1991; 79: 229–243
  • Kuş C, Ayhan-Kılcıgil G, Can-Eke B, Işcan M. Synthesis and antioxidant properties of some novel benzimidazole derivatives on lipid peroxidation in the rat liver. Arch Pharm Res 2004; 27(2)156–163
  • Ayhan-Kılcıgil G, Kuş C, Çoban T, Can-Eke B, İşcan M. Synthesis and antioxidant properties of novel benzimidazole derivatives. J Enz Inhib Med Chem 2004; 19(2)129–135
  • Ayhan-Kılcıgil G, Kuş C, Çoban T, Can-Eke B, Özbey S, Iscan M. Synthesis, antioxidant and radical scavenging activities of novel benzimidazoles. J Enz Inhib Med Chem 2005; 20(5)503–514
  • Ayhan-Kılcıgil G, Kuş C, Altanlar N, Özbey S. Synthesis and antimicrobial evaluation of some new 2-(2-(p-chlorophenyl) benzimidazol-1-yl methyl)-5-substituted amino-[1,3,4]-thiadiazoles. Turkish J Chem 2005; 29: 153–162
  • Kuş C, Ayhan-Kılcıgil G, Altanlar N. Antimicrobial activity of some thiadiazolyl- and triazolylbenzimidazoles. J Fac Pharm Ankara 2004; 33(1)1–6
  • Iscan M, Arinç E, Vural N, Iscan MY. In vivo effects of 3-methylcholantrene, phenobarbital, pyretrum and 2.4.5-T isooctylester on liver, lung and kidney microsomal mixed-function oxidase system of guinea-pig: A comparative study. Comp Biochem Physiol 1984; 77C: 177–190
  • Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J 1966; 99: 667–676
  • Wills ED. Lipid peroxide formation in microsomes. Relationship of hydroxylation to lipid peroxide formation. Biochem J 1969; 113: 333–341
  • Bishayee S, Balasubramanian AS. Lipid peroxide formation in rat brain. Neurochem 1971; 18: 909–920
  • Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, penthoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 1985; 34: 3337–3345
  • Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Amer J Clin Pathol 1996; 45(4)493–496
  • Hall HJ, Kamm DR. Synthesis of benzimidazoles from anils of o-Azidoaniline. J Org Chem 1965; 30: 2092–2093
  • Ridley HF, Spickett RGW, Timmis GM. A new synthesis of benzimidazoles and aza analogs. J Heter Chem 1965; 2: 453–456

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.